AFANIX 40 MG
Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose
LORBREXEN 100 MG
LORBREXEN 100 MG/*54745756836*/
SUNITIX 25 MG
Sunitix Capsule Sunitinib 25 mg Beacon Pharmaceuticals Ltd. Indications Gastrointestinal Stromal Tumor (GIST): Sunitinib is indicated for the treatment of gastrointestinal
TOFACINIX 11 MG
Tofacinix Tablet (Extended Release) Tofacitinib 11 mg Beacon Pharmaceuticals Ltd. Indications Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult